Mexiletine
Mexiletine is an approved active ingredient.
Pair of enantiomers
Boxed warning (US label)
Warnings. BOXED Mortality In the National Heart, Lung and Blood Institute’s Cardiac Arrhythmia Suppression Trial (CAST), a long-term, multicentered, randomized, double-blind study in patients with asymptomatic non-life-threatening ventricular arrhythmias who had a…
What it is used for
- Diabetic polyneuropathy
- Ventricular fibrillation
- Heart arrhythmia
- Myotonic disease
Mexiletine Hydrochloride Capsules USP are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life- threatening.
Namuscla is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders.
How it works
- Sodium channel alpha subunit blocker
Common side effects
In the three month controlled trials comparing mexiletine to quinidine, procainamide and disopyramide, the most frequent adverse reactions were upper gastrointestinal distress (41%), lightheadedness (10.5%), tremor (12.6%) and coordination difficulties (10.2%).
Who should not take it
Mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or preexisting second- or third-degree AV block (if no pacemaker is present).
Pregnancy and breastfeeding
Teratogenic Effects Reproduction studies performed with mexiletine in rats, mice and rabbits at doses up to four times the maximum human oral dose (24 mg/kg in a 50 kg patient) revealed no evidence of teratogenicity or impaired fertility but did show an…
Mexiletine appears in human milk in concentrations similar to those observed in plasma. Therefore, if the use of mexiletine hydrochloride is deemed essential, an alternative method of infant feeding should be considered.
Interactions
- Cimetidine
- Fluvoxamine
- Lidocaine
- Phenobarbital
- Phenytoin
- Propranolol
- Quinidine
- Rifampicin
- Ritonavir
- Tizanidine
Brand names
United States
Mexitil
European Union
Namuscla
Canada
Mint-Mexiletine · Teva-Mexiletine
Other trade names
Mexitil p.l.
Approval status
- US Food and Drug Administration
- prescription · since 1985
- European Medicines Agency
- authorised · since 2018
- Health Canada
- prescription · marketed
- First approval anywhere
- 1985
Codes
- ATC
- C01BB02
- RxNorm CUI
- 6926
- ChEMBL
- CHEMBL558
- PubChem CID
- 4178
- UNII
- 1U511HHV4Z
- Wikidata
- Q420377
Frequently asked questions
What is Mexiletine used for?
Mexiletine is used for: Diabetic polyneuropathy, Ventricular fibrillation, Heart arrhythmia, and Myotonic disease.
What are the brand names of Mexiletine?
Brand names of Mexiletine include Mexitil, Namuscla, Mint-Mexiletine, Teva-Mexiletine, and Mexitil p.l..
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)